Watch GUTS. Know when insiders buy.
One email the day a filing lands. Free.
GUTS
FRACTYL HEALTH, INC.
0.56
−0.00 −0.35%
USD · close Sep 16
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
79
PASS · insiders 57, shorts 100
Insiders, 90 days
+$40K
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $89.6MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$105.7MNET CASH —52W 0.39 – 2.37SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$19.1M | −$25.5M | — | -0.16 | −$15.9M | — | — | Aug 10 |
| Q1 2026 · Mar 31 | — | — | — | −$20.8M | $9.2M | — | 0.06 | −$22.5M | — | — | Aug 10 |
| Q4 2025 · Dec 31derived | — | — | — | −$23.3M | −$43.7M | — | -0.07 | −$21.3M | $3K | −$21.3M | Mar 24 |
| Q3 2025 · Sep 30 | — | — | — | −$22.7M | −$45.6M | — | -0.71 | −$22.7M | $8K | −$22.7M | Nov 12 |
| Q2 2025 · Jun 30 | — | — | — | −$26.1M | −$27.9M | — | -0.57 | −$21.2M | $98K | −$21.3M | Aug 10 |
| Q1 2025 · Mar 31 | — | — | — | −$24.8M | −$23.7M | — | -0.49 | −$25.1M | $448K | −$25.5M | Aug 10 |
| Q4 2024 · Dec 31derived | — | — | — | −$25.2M | −$25M | — | -0.53 | −$17M | $233K | −$17.3M | Mar 24 |
| Q3 2024 · Sep 30 | — | — | — | −$23.8M | −$23.2M | — | -0.48 | −$18M | $213K | −$18.3M | Nov 12 |
| Q2 2024 · Jun 30 | — | — | — | −$23M | −$17.2M | — | -0.36 | −$18.7M | $260K | −$19M | Nov 12 |
| Q1 2024 · Mar 31 | — | — | — | −$21.5M | −$3.3M | — | -0.17 | −$11.7M | $1.1M | −$12.8M | Nov 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$13M | −$19.2M | — | -11.18 | −$10.6M | $136K | −$10.7M | Mar 3 |
| Q3 2023 · Sep 30 | — | — | — | −$13.9M | −$15.7M | — | -9.61 | −$11M | $148K | −$11.2M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$96.8M | −$141M | — | -1.86 | −$90.3M | $557K | −$90.9M | — | — |
| FY2024 · to Dec 31 | — | — | −$93.5M | −$68.7M | — | -1.62 | −$65.5M | $1.8M | −$67.3M | — | — |
| FY2023 · to Dec 31 | — | — | −$50.8M | −$77.1M | — | -45.29 | −$42.8M | $359K | −$43.2M | — | — |
Every number comes from FRACTYL HEALTH, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.